Logo image of 1CVA.MI

CLEVELAND-CLIFFS INC (1CVA.MI) Stock Fundamental Analysis

BIT:1CVA - Euronext Milan - US1858991011 - Common Stock - Currency: EUR

6.818  +0.45 (+7.02%)

Fundamental Rating

2

Taking everything into account, 1CVA scores 2 out of 10 in our fundamental rating. 1CVA was compared to 36 industry peers in the Metals & Mining industry. Both the profitability and financial health of 1CVA have multiple concerns. 1CVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year 1CVA has reported negative net income.
In the past year 1CVA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1CVA reported negative net income in multiple years.
Of the past 5 years 1CVA 4 years had a positive operating cash flow.
1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

1CVA has a Return On Assets of -3.60%. This is in the lower half of the industry: 1CVA underperforms 77.78% of its industry peers.
With a Return On Equity value of -11.31%, 1CVA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.6%
ROE -11.31%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
1CVA.MI Yearly ROA, ROE, ROIC1CVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

1CVA has a Gross Margin of 0.36%. This is amonst the worse of the industry: 1CVA underperforms 91.67% of its industry peers.
In the last couple of years the Gross Margin of 1CVA has declined.
1CVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-74.57%
GM growth 5Y-58.3%
1CVA.MI Yearly Profit, Operating, Gross Margins1CVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

1CVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1CVA has less shares outstanding
1CVA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CVA has a worse debt to assets ratio.
1CVA.MI Yearly Shares Outstanding1CVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1CVA.MI Yearly Total Debt VS Total Assets1CVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that 1CVA is in the distress zone and has some risk of bankruptcy.
1CVA's Altman-Z score of 1.27 is on the low side compared to the rest of the industry. 1CVA is outperformed by 77.78% of its industry peers.
1CVA has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
1CVA has a Debt to Equity ratio of 1.11. This is amonst the worse of the industry: 1CVA underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACCN/A
WACC7.72%
1CVA.MI Yearly LT Debt VS Equity VS FCF1CVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.08 indicates that 1CVA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.08, 1CVA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
1CVA has a Quick Ratio of 2.08. This is a bad value and indicates that 1CVA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.55, 1CVA is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 0.55
1CVA.MI Yearly Current Assets VS Current Liabilites1CVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

1CVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -284.85%.
Looking at the last year, 1CVA shows a very negative growth in Revenue. The Revenue has decreased by -12.78% in the last year.
1CVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.33% yearly.
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
Revenue 1Y (TTM)-12.78%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%

3.2 Future

The Earnings Per Share is expected to grow by 35.11% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1CVA will show a small growth in Revenue. The Revenue will grow by 1.94% on average per year.
EPS Next Y21.93%
EPS Next 2Y52.57%
EPS Next 3Y35.11%
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y4.9%
Revenue Next 3Y4.9%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVA.MI Yearly Revenue VS Estimates1CVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
1CVA.MI Yearly EPS VS Estimates1CVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

1CVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 19.00 indicates a rather expensive valuation of 1CVA.
1CVA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1CVA is more expensive than 61.11% of the companies in the same industry.
1CVA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.13.
Industry RankSector Rank
PE N/A
Fwd PE 19
1CVA.MI Price Earnings VS Forward Price Earnings1CVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

1CVA's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. 1CVA is more expensive than 80.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.22
1CVA.MI Per share data1CVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CVA's earnings are expected to grow with 35.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.57%
EPS Next 3Y35.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1CVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEVELAND-CLIFFS INC

BIT:1CVA (6/9/2025, 7:00:00 PM)

6.818

+0.45 (+7.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners74.09%
Inst Owner ChangeN/A
Ins Owners1.52%
Ins Owner ChangeN/A
Market Cap3.37B
Analysts68.89
Price Target10.14 (48.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.98%
Min EPS beat(2)-90.92%
Max EPS beat(2)-49.04%
EPS beat(4)1
Avg EPS beat(4)-14.67%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)2.54%
EPS beat(12)5
Avg EPS beat(12)-5.94%
EPS beat(16)6
Avg EPS beat(16)-9.78%
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-5.15%
Max Revenue beat(2)-3.31%
Revenue beat(4)0
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-3.12%
Revenue beat(8)2
Avg Revenue beat(8)-1.8%
Revenue beat(12)4
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-1.19%
PT rev (1m)-13.22%
PT rev (3m)-24.01%
EPS NQ rev (1m)-5.27%
EPS NQ rev (3m)-390.36%
EPS NY rev (1m)-47.04%
EPS NY rev (3m)-643.32%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-4.1%
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19
P/S 0.2
P/FCF N/A
P/OCF 36.96
P/B 0.58
P/tB 1.04
EV/EBITDA 25.22
EPS(TTM)-2.12
EYN/A
EPS(NY)0.36
Fwd EY5.26%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)0.18
OCFY2.71%
SpS33.7
BVpS11.71
TBVpS6.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -11.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.36%
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-74.57%
GM growth 5Y-58.3%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 16.52
Cap/Depr 73.08%
Cap/Sales 3.62%
Interest Coverage N/A
Cash Conversion 23.49%
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 0.55
Altman-Z 1.27
F-Score4
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
EPS Next Y21.93%
EPS Next 2Y52.57%
EPS Next 3Y35.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.78%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%
Revenue Next Year4.09%
Revenue Next 2Y4.9%
Revenue Next 3Y4.9%
Revenue Next 5Y1.94%
EBIT growth 1Y-164.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year334.37%
EBIT Next 3Y79.36%
EBIT Next 5Y47.39%
FCF growth 1Y-136.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.37%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%